A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease
Clinical trial NCT03737214 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03737214
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-18
- Primary completion
- 2029-08-01
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.